Clinical effect of remazolam besylate combined with alfentanil in gastroscopy: a prospective cohort study

Comparison of the clinical effects of remazolam besylate combined with alfentanil and propofol combined with remifentanil in gastroscopy: a prospective cohort study

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000040058

Enrollment

Unknown

Registered

2020-11-19

Start date

2020-12-15

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastroscopic procedure

Interventions

Control group:propofol+Remifentanil

Experimental group:Remazolam combined with alfentanil

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing simple gastroscopy; 2. Age 18-65 years old, regardless of gender; 3. American Society of Anesthesiologists (ASA) graded I-III.

Exclusion criteria

Exclusion criteria: 1. Patients undergoing emergency surgery; 2. Patients requiring general anesthesia for tracheal intubation; 3. Cases with incomplete data.

Design outcomes

Primary

Measure	Time frame
Incidence of respiratory depression;Rate of sedation success;	—

Secondary

Measure	Time frame
Heart rate;blood pressure;	—

Countries

China

Contacts

Public ContactLv yunqi

The First Affiliated Hospital of Zhengzhou University

yymchelong@126.com+86 13939019005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026